(MENAFN- ABN Newswire) 
Update on Prefeasibility Study for Large Clayton Valley Lithium Project in NevadaVancouver, June 25, 2019 AEST (ABN Newswire) - Ellis Martin chats with Dr. William Willoughby of Cypress Development Corp ( 
CVE:CYP ) ( OTCMKTS:CYDVF ) providing an update on the prefeasibility study for the company's large 100% owned Clayton Valley Lithium Project in Nevada.
To view the Video Audio, please visit:
http://www.abnnewswire.net/press/en/98370/Cypress
About Cypress Development Corp.
Cypress Development Corp.( CVE:CYP ) ( OTCMKTS:CYDVF ) is a publicly traded exploration company focused on developing the Company's 100%-owned Clayton Valley Lithium Project in Nevada. Exploration and development by Cypress has discovered a world-class resource of lithium-bearing claystone adjacent to Albemarle's Silver Peak mine, North America's only lithium brine operation. The size of the resource makes the Clayton Valley Project a premier target that has the potential to impact the future supply of lithium for the fast-growing global lithium-ion battery market.
Cypress Development Corp. has approx. 74.3 million shares issued and outstanding.
To find out more about Cypress Development Corp. (CVE:CYP), visit our website athttp://www.cypressdevelopmentcorp.com
About The Ellis Martin Report
The Ellis Martin Report (TEMR) is an internet based radio program showcasing potentially undervalued companies to an audience of potential retail investors and fund managers that comprise our listening audience. TEMR is broadcasted on the VoiceAmerica Business Channel and The Opportunity Radio Network. CEO and company interviews are paid for by those represented on the program.
MENAFN2506201901110000ID1098681299
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.